Steady Expansion Forecast for Research-Grade Proteins Market, Projected to Reach $2.9 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Research-Grade Proteins Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for research-grade proteins has seen substantial expansion in the past few years. The projection is for it to go from $1.11 billion in 2024 to $1.35 billion in 2025, experiencing a compound annual growth rate (CAGR) of 21.4%. Several factors contribute to this historical growth, including augmenting research endeavors, an upswing in R&D efforts within the pharmaceutical and biotechnology sectors, a surging demand for personalized medicine, increased funding from governmental and academic institutions, and carefully planned acquisitions and partnerships.

Research-Grade Proteins Market Size Forecast: What's the Projected Valuation by 2029?
The market size of research-grade proteins is forecasted to experience a surge in the upcoming years, increasing to $2.9 billion in 2029, with a compound annual growth rate (CAGR) of 21.2%. The drivers for expansion in the projected period are breakthroughs in proteomics research, a rising count of clinical trials, unification of AI and data analytics, the application of research-grade proteins in industrial settings, and an escalated need for sophisticated research instruments. Crucial trends during the forecasted period encompass rising cognizance of pioneering technologies, advancements in the biotechnological sector, progress made in genomics and proteomics, burgeoning application in drug generation, and high-end research tools in the sectors of biotechnology and pharmaceuticals.

View the full report here:
https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What Are the Drivers Transforming the Research-Grade Proteins Market?
The surge in clinical trials is anticipated to fuel the expansion of the research-grade proteins market. Clinical trials are research studies that evaluate the safety and efficacy of novel medical treatments, interventions, or devices in people. Due to advancements in medical research, disease burden, regulatory changes, patient needs, and industry investment, the number of clinical trials is on the rise. Research-grade proteins contribute importantly to clinical trials as fundamental tools for developing biomarkers, assay development, identifying drug targets, quality control, and establishing reference standards, thereby ensuring the dependability and precision of experimental data. For example, the US-based clinical trial registry, ClinicalTrials.gov, indicated that by the end of 2023, the number of registered clinical trials globally had reached 477,234 on ClinicalTrials.gov, a rise from the 437,512 clinical trials registered in 2022. So, the escalating number of clinical trials is propelling the growth of the research-grade proteins market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

What Long-Term Trends Will Define the Future of the Research-Grade Proteins Market?
Leading businesses in the research-grade proteins market are advancing the development of Cas9 proteins to boost their effectiveness and relevance in genome editing and other fields of biotechnology. Cas9 proteins, serving as molecular scissors, facilitate genome editing by slicing DNA at sites predetermined by a guide RNA (gRNA). For example, in April 2022, Thermo Fisher Scientific Inc., a biotechnology firm from the US, launched a creative GMP-manufactured Gibco CTS TrueCut Cas9 Protein. This high-quality, clinically approved Cas9 protein, produced in adherence to Good Manufacturing Practice (GMP) standards, is intended for genome editing applications. It delivers high purity and functionality specifically designed for CRISPR-based research, fostering progress in genetic engineering and the development of therapeutics.

Which Segments in the Research-Grade Proteins Market Offer the Most Profit Potential?
The research-grade proteins market covered in this report is segmented -

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells
3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:
1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor
2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies
3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens
5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases
6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers
7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline
8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

Which Firms Dominate the Research-Grade Proteins Market by Market Share and Revenue in 2025?
Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

Which Regions Offer the Highest Growth Potential in the Research-Grade Proteins Market?
North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.